Allergy and Immunology, Allergy · Topeka, KS
NPI
1346463825
Since 2007
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
909 SW Mulvane St Lowr Level
Topeka, KS, 66606
Phone (785) 270-4613
Groups this clinician bills Medicare through
Medicare paid, 2024
$331K
5,806 services
Medicare patients, 2024
1,023
Average age 75
Drug cost, 2024
$1.3M
4,336 prescriptions
Company payments, 2025
$15.95
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bilal Q Khan was code 99232 (hospital e&m - subsequent), 2,915 times for 466 patients. In total Bilal Q Khan billed 5,806 services in 29 codes, and Medicare paid $331K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,915 | 466 | $57.68 | $168K |
| 99214 Office E&M - Established | Office | 783 | 442 | $79.83 | $63K |
| 95165 Treatment - Miscellaneous | Office | 395 | 31 | $8.86 | $3,499 |
| 95117 Treatment - Miscellaneous | Office | 386 | 33 | $7.68 | $2,963 |
| 99233 Hospital E&M - Subsequent | Facility | 354 | 83 | $87.28 | $31K |
| 99223 Hospital E&M - Initial | Facility | 327 | 304 | $127.15 | $42K |
| 95018 Test - Miscellaneous | Office | 178 | 18 | $14.41 | $2,565 |
| 99204 Office E&M - New | Office | 86 | 86 | $105.12 | $9,040 |
| 95115 Treatment - Miscellaneous | Office | 86 | 17 | $6.53 | $562 |
| 36415 Venipuncture Blood Collection | Office | 64 | 45 | $8.41 | $538 |
| 95076 Test - Miscellaneous | Office | 25 | 19 | $84.99 | $2,125 |
| 99214 Office E&M - Established | Facility | 17 | 11 | $70.64 | $1,201 |
| 99213 Office E&M - Established | Office | 13 | 12 | $51.68 | $672 |
By year: 2022 $196K for 4,035 services; 2023 $209K for 3,770 services; 2024 $331K for 5,806 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 64 | 45 | $8.41 | $538 |
Medicare prescription drug claims, 2024
In 2024, the drug Bilal Q Khan prescribed most often to Medicare patients was Montelukast Sodium, with 1,380 prescriptions and refills. In total Bilal Q Khan wrote 4,336 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,380 | 3,674 | 380 | $13K |
| Hydroxyzine Hcl Generic | 475 | 985 | 144 | $5,009 |
| Fluticasone Propionate Generic | 409 | 981 | 158 | $12K |
| Azelastine Hcl Generic | 187 | 364 | 75 | $6,543 |
| Ipratropium Bromide Generic | 169 | 277 | 69 | $6,580 |
| Famotidine Generic | 129 | 330 | 43 | $1,696 |
| Incruse Ellipta Umeclidinium Bromide | 115 | 160 | 21 | $55K |
| Cyproheptadine Hcl Generic | 101 | 216 | 29 | $4,013 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 94 | 162 | 22 | $20K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 93 | 105 | 56 | $2,756 |
| Advair Hfa Fluticasone Propion/Salmeterol | 83 | 111 | 19 | $45K |
| Epinephrine Generic | 71 | 74 | 58 | $13K |
| Prednisolone Acetate Generic | 55 | 69 | 22 | $4,666 |
| Dupixent Pen Dupilumab | 53 | 53 | Under 11 | $196K |
| Arnuity Ellipta Fluticasone Furoate | 52 | 76 | 11 | $17K |
Brand drugs: - claims; generic drugs: 3,391 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bilal Q Khan $15.95 ($15.95 in general payments such as food, travel and fees) from 1 company. The largest payer was Philips North America LLC with $15.95.
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC PHG | 1 | $15.95 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.